HF
PASG icon

HRT Financial’s Passage Bio PASG Stock Holding History

HRT Financial’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62K Buy
+12,712
New +$79.5K ﹤0.01% 3721
2025
Q1 		– Sell
-693
Closed -$7K – 3168
2024
Q4 		$7K Buy
+693
New +$9.03K ﹤0.01% 2308
2023
Q2 		– Sell
-986
Closed -$18K – 3049
2023
Q1 		$18K Buy
+986
New +$26.7K ﹤0.01% 2192
2022
Q1 		– Sell
-774
Closed -$98K – 3657
2021
Q4 		$98K Sell
774
-3,252
-81% -$531K ﹤0.01% 2768
2021
Q3 		$801K Buy
+4,026
New +$960K ﹤0.01% 1502

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

HRT Financial's PASG Position: Q2 2026 in Review

HRT Financial opened a new position in Passage Bio (PASG) in Q2 2026: 12,712 shares worth $62K. The stake represents ﹤0.01% of the portfolio and ranks #3721 among its holdings. This is a return to the name: HRT Financial previously reported a position in PASG as recently as Q4 2024.

HRT Financial first reported a position in PASG in Q3 2021 and has held it in 5 quarters since. The position peaked at $801K in Q3 2021. 29 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • HRT Financial held 12,712 shares of Passage Bio worth $62K as of Q2 2026.
  • Passage Bio was a new HRT Financial position in Q2 2026.
  • Passage Bio made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3721 holding.
  • HRT Financial first reported a position in Passage Bio in Q3 2021 and has held it in 5 quarters since.
  • HRT Financial's Passage Bio position peaked at $801K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.